Vered Caplan - 28 Jan 2022 Form 4 Insider Report for Orgenesis Inc. (ORGS)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ORGS
Reported as of: 28 Jan 2022
Net transaction value: +$3,338
SEC form: 4
Accepted by SEC: 02 Feb 2022, 16:18:15 UTC
Next SEC filing: 16 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Vered Caplan

Key filing fact

Vered Caplan filed Form 4 for Orgenesis Inc. (ORGS) on 02 Feb 2022.

Key facts

This page summarizes Vered Caplan's Form 4 filing for Orgenesis Inc. (ORGS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Feb 2022, 16:18.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$3,338.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORGS transaction

Common Stock

Options Exercise

Transaction value: $3,338
Shares: +278,191
Change %
Price: $0.0120^*
Shares after: 278,191
Date: 28 Jan 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORGS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -278,191
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 28 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 278,191
Exercise price: $0.0120
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options were awarded on July 10, 2012 under the Issuer's 2012 Stock Option Plan to purchase shares of common stock of the Issuer and vested in two equal annual installments.